Recommended Treatment for H. pylori Infection
Bismuth quadruple therapy for 14 days is the preferred first-line treatment regimen for H. pylori infection when antibiotic susceptibility is unknown, with an eradication rate of approximately 85%. 1
First-Line Treatment Options
When antibiotic susceptibility is unknown:
Bismuth quadruple therapy (14 days) 1, 2
- Preferred regimen due to increasing clarithromycin resistance worldwide
- Eradication rate: approximately 85%
Concomitant non-bismuth quadruple therapy (14 days) 1, 3
- Alternative first-line option
- Eradication rate: approximately 80%
- Particularly useful in areas with high clarithromycin resistance (≥15%)
- Consists of:
- 1 gram amoxicillin twice daily
- 500 mg clarithromycin twice daily
- 30 mg lansoprazole twice daily
- Only recommended in areas with low clarithromycin resistance (<15%)
- Eradication rate: approximately 85% when resistance is low
- Consists of:
Second-Line Treatment Options
If first-line therapy fails, second-line treatment should avoid antibiotics previously used 1:
Levofloxacin-based triple therapy (14 days) 3, 5
- Option when bismuth quadruple therapy was used first-line
Bismuth quadruple therapy (14 days) 3
- If not previously used as first-line treatment
Treatment After Multiple Failures
For patients who have failed two previous treatment attempts 1, 2:
- Rifabutin-based triple therapy
- High-dose dual therapy
- Antimicrobial susceptibility testing (AST) should be performed to guide therapy
Special Considerations
Penicillin Allergy
- Patients with true penicillin allergy can be treated with bismuth quadruple therapy using tetracycline instead of amoxicillin 1
- Alternative regimens using levofloxacin or other bismuth-based therapies may be considered
Antibiotic Resistance
- Increasing resistance to clarithromycin, levofloxacin, and metronidazole is a major cause of treatment failure 1, 6
- Local antibiotic resistance patterns should guide therapy selection when available
Confirmation of Eradication
- Wait at least 4 weeks after completing antibiotic therapy before testing for H. pylori eradication 1
- Preferred tests:
- Urea Breath Test (UBT) - gold standard non-invasive test (sensitivity 95%, specificity 90%)
- Monoclonal stool antigen test - equivalent accuracy to UBT
Important Clinical Pearls
- Antibiotic stewardship: To reduce the development of drug-resistant bacteria, amoxicillin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria 4
- Medication timing: To minimize gastrointestinal intolerance, amoxicillin should be taken at the start of a meal 4
- Dietary management: A diet low in acidic, spicy, and fatty foods, along with regular consumption of fruits and vegetables rich in vitamin C, is recommended for patients with epigastric pain and a history of H. pylori infection 1
- Surveillance: Patients with risk factors for gastric cancer or atrophic gastritis should undergo surveillance endoscopy every 3 years 1
- Alarm symptoms: Patients aged ≥55 or with alarm symptoms should be referred for prompt endoscopy with H. pylori testing 1
Common Pitfalls to Avoid
- Using clarithromycin-based regimens in areas with high resistance - This leads to treatment failure and further resistance development
- Inadequate treatment duration - 14-day regimens are superior to shorter courses
- Not confirming eradication - All patients should undergo testing to confirm successful eradication
- Testing too soon after treatment - Wait at least 4 weeks after antibiotics to avoid false negative results
- Reusing previously failed antibiotics - Second-line therapy should avoid antibiotics used in failed first-line regimens